We are live on ! Find out more
Goldman Sachs

Goldman Sachs Portfolio holdings

AUM $871B
1-Year Est. Return 31.28%
 

Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.

This Fund
S&P 500
This Quarter Est. Return
+8.54%
1 Year Est. Return
+31.28%
3 Year Est. Return
+94.73%
5 Year Est. Return
+114.04%
10 Year Est. Return
+476.55%
AUM
$446B
AUM Growth
+$49.9B
Cap. Flow
+$20.1B
Cap. Flow %
4.51%
Top 10 Hldgs %
17.27%
Holding
6,869
New
821
Increased
2,556
Reduced
2,333
Closed
700

Sector Composition

Rank Sector Weight
1 Technology 14.59%
2 Consumer Discretionary 9.73%
3 Financials 8.55%
4 Healthcare 8.03%
5 Communication Services 6.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HBMD
5376
DELISTED
Howard Bancorp, Inc. Common Stock
HBMD
$330K ﹤0.01%
20,468
-9,381
-31% -$155K
EML icon
5377
Eastern Company
EML
$143M
$329K ﹤0.01%
+10,855
New +$324K
ERO icon
5378
Ero Copper
ERO
$2.81B
$329K ﹤0.01%
+15,631
New +$319K
IESC icon
5379
IES Holdings
IESC
$14.8B
$329K ﹤0.01%
6,413
-31,107
-83% -$1.61M
INZY
5380
DELISTED
Inozyme Pharma
INZY
$329K ﹤0.01%
19,310
-4,480
-19% -$77.9K
BMTX.WS
5381
DELISTED
BM Technologies, Inc. Warrants, each warrant exercisable for one share of Common Stock at an exercise price of $11.50
BMTX.WS
$329K ﹤0.01%
128,200
CALB
5382
DELISTED
California BanCorp Common Stock
CALB
$327K ﹤0.01%
+17,461
New +$312K
GAPA.WS
5383
DELISTED
G&P Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
GAPA.WS
$327K ﹤0.01%
+488,213
New +$297K
AMPE
5384
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$327K ﹤0.01%
654
-416
-39% -$223K
ODT
5385
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
$327K ﹤0.01%
93,818
+20,581
+28% +$70.7K
LXRX icon
5386
Lexicon Pharmaceuticals
LXRX
$1.03B
$326K ﹤0.01%
70,988
+5,929
+9% +$28.6K
SPXV icon
5387
ProShares S&P 500 ex-Health Care ETF
SPXV
$39.4M
$326K ﹤0.01%
+7,226
New +$318K
SNCR
5388
DELISTED
Synchronoss Technologies
SNCR
$325K ﹤0.01%
10,052
-21,303
-68% -$599K
CLX icon
5389
PUT
Clorox
CLX
$11.6B
$324K ﹤0.01%
1,800
-5,300
-75% -$967K
TLK icon
5390
Telkom Indonesia
TLK
$14.5B
$322K ﹤0.01%
+14,871
New +$344K
HURC icon
5391
Hurco Companies Inc
HURC
$135M
$321K ﹤0.01%
9,180
-7,890
-46% -$275K
SOXS icon
5392
Direxion Daily Semiconductor Bear 3X ETF
SOXS
$1.93B
$321K ﹤0.01%
2
-2
-50% -$356K
TWNT.WS
5393
DELISTED
Tailwind Two Acquisition Corp. Redeemable warrants included as part of the units, each whole warrant
TWNT.WS
$321K ﹤0.01%
+321,050
New +$258K
MG icon
5394
Mistras Group
MG
$484M
$320K ﹤0.01%
32,535
-15,007
-32% -$162K
PSCM icon
5395
Invesco S&P SmallCap Materials ETF
PSCM
$20.2M
$319K ﹤0.01%
+4,953
New +$326K
VFF icon
5396
Village Farms International
VFF
$234M
$319K ﹤0.01%
+29,879
New +$315K
CGEM icon
5397
Cullinan Oncology
CGEM
$1.01B
$318K ﹤0.01%
12,353
-43,707
-78% -$1.34M
PDLB icon
5398
Ponce Financial Group
PDLB
$488M
$318K ﹤0.01%
+32,439
New +$284K
CMBT
5399
CMB.TECH NV
CMBT
$4.69B
$318K ﹤0.01%
34,142
-860,275
-96% -$7.84M
ABUS icon
5400
Arbutus Biopharma
ABUS
$857M
$317K ﹤0.01%
104,484
+59,845
+134% +$185K

Similar funds

Goldman Sachs's Q2 2021 Portfolio in Review

As of Q2 2021, Goldman Sachs held 6,869 positions worth $446B, up 13% from $396B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Goldman Sachs deployed $20.1B of net new capital in Q2 2021, opening 821 new positions and adding to 2,556 existing holdings. Its largest new stake was Privia Health: 30,513,629 shares worth $1.35B.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $960M trimmed.

  • Goldman Sachs's largest Q2 2021 buy was Privia Health: 30,513,629 shares worth $1.35B.
  • Goldman Sachs added most to Alibaba in Q2 2021, an estimated $1.31B increase.
  • Goldman Sachs's biggest Q2 2021 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $960M.
  • Goldman Sachs fully exited Pluralsight, Inc. Class A Common Stock in Q2 2021, selling an estimated $128M.
  • Goldman Sachs's ten largest holdings make up 17% of its $446B portfolio in Q2 2021.
  • Goldman Sachs opened 821 new positions and closed 700 in Q2 2021.
  • Goldman Sachs's portfolio value rose 13% quarter-over-quarter to $446B.

Based on Goldman Sachs's 13F filing for Q2 2021, filed 13 Aug 2021.